Thank you for sharing!

Your article was successfully shared with the contacts you provided.

(To read more on the industrial market, click here.)

FRAMINGHAM, MA-Biotech giant Genzyme Corp. will begin construction next month on a six-story, glass-enclosed research building here that will be part of a three-building, $210-million manufacturing and research expansion project slated for Massachusetts.

The firm is also adding a $53-million expansion within its Allston Landing cell-culture manufacturing facility that will increase manufacturing capacity by 50%; and, it plans a $33.5-million expansion of laboratories in Waltham, including the construction of a second research building.

“We anticipate continued growth over the next five years and anticipate these new buildings will provide for that need,” a Genzyme spokeswoman tells GlobeSt.com.

The 177,000-sf Framingham facility, which will open in 2007 at 45 New York Ave., will house early stage scientific research and incorporate energy efficient design similar to those used at the firm’s landmark headquarters in Cambridge when it opens in 2007. As part of that project, Genzyme will participate in the Labs 21 program, an EPA program with the goal to improve the environmental performance of laboratory space in the US. As part of that participation, Genzyme will include green features such as sophisticated heating and cooling systems, low flow water fixtures and plantings that require minimal water, into the design. The project also includes a separate utility building that will provide steam and cooled water along with other utilities to the new building and three other Genzyme buildings on the Framingham campus.

The new Waltham facility, which will be located adjacent to Genzyme’s existing facility at 150 Second Ave., also will incorporate energy efficient concepts. The expansion at Genzyme’s Allston Landing facility calls for the construction of a 1.5 megawatt cogeneration plant which will produce all of the facility’s steam needs and 75% of its electricity. Construction on that plant will begin in August of next year with completion slated for the end of 2008.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.